Nifedipine Market Report

Nifedipine Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Mar 23, 2020
  • PAGES：168
  • REPORT CODE：GMM517876
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Nifedipine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period.

    This report presents the market size and development trends by detailing the Nifedipine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Nifedipine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Nifedipine industry and will help you to build a panoramic view of the industrial development.

    Nifedipine Market, By Type:

    • Nifedipine Controlled Release Tablets

    • Nifedipine Extended Action Tablets

    Nifedipine Market, By Application:

    • Primary Pulmonary Hypertension

    • Heart Failure

    • Others

    Some of the leading players are as follows:

    • Yabao (China)

    • Pfizer (USA)

    • Bayer (Germany)

    • Honglin (China)

    • Teva (Israel)

    • Actavis (USA)

    • Huanghai (China)

    • Shyndec (China)

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Nifedipine Market: Technology Type Analysis

    • 4.1 Nifedipine Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Nifedipine Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Nifedipine Controlled Release Tablets

      • 4.3.2 Nifedipine Extended Action Tablets

    5 Nifedipine Market: Product Analysis

    • 5.1 Nifedipine Product Market Share Analysis, 2018 & 2026

    • 5.2 Nifedipine Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Nifedipine Market: Application Analysis

    • 6.1 Nifedipine Application Market Share Analysis, 2018 & 2026

    • 6.2 Nifedipine Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Primary Pulmonary Hypertension

      • 6.3.2 Heart Failure

      • 6.3.3 Others

    7 Nifedipine Market: Regional Analysis

    • 7.1 Nifedipine Regional Market Share Analysis, 2018 & 2026

    • 7.2 Nifedipine Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Yabao (China)

      • 9.1.1 Yabao (China) Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Pfizer (USA)

      • 9.2.1 Pfizer (USA) Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Bayer (Germany)

      • 9.3.1 Bayer (Germany) Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Honglin (China)

      • 9.4.1 Honglin (China) Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Teva (Israel)

      • 9.5.1 Teva (Israel) Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Actavis (USA)

      • 9.6.1 Actavis (USA) Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Huanghai (China)

      • 9.7.1 Huanghai (China) Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Shyndec (China)

      • 9.8.1 Shyndec (China) Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

     

    The List of Tables and Figures (Totals 79 Figures and 125 Tables)

    • Figure Nifedipine Controlled Release Tablets Nifedipine market, 2015 - 2026 (USD Million)

    • Figure Nifedipine Extended Action Tablets Nifedipine market, 2015 - 2026 (USD Million)

    • Figure Primary Pulmonary Hypertension market, 2015 - 2026 (USD Million)

    • Figure Heart Failure market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Nifedipine market, by country, 2015 - 2026 (USD Million)

    • Table North America Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table North America Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table North America Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Canada Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Canada Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Europe Nifedipine market, by country, 2015 - 2026 (USD Million)

    • Table Europe Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Europe Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Europe Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Germany Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Germany Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table France Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table France Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Italy Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Italy Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Spain Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Spain Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nifedipine market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table China Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table China Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Japan Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Japan Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table India Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table India Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Nifedipine market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table MEA Nifedipine market, by country, 2015 - 2026 (USD Million)

    • Table MEA Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table MEA Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table MEA Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Nifedipine market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Nifedipine market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Nifedipine market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Yabao (China) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer (USA) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer (Germany) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Honglin (China) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Teva (Israel) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Actavis (USA) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Huanghai (China) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shyndec (China) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US